Carol R Reed

Title: The Innovations of Carol R Reed

Introduction

Carol R Reed is an accomplished inventor based in Bethany, CT (US). She has made significant contributions to the field of genetics, particularly in relation to cognitive response and treatment for Alzheimer's disease. Her innovative work has led to the development of a patent that holds promise for improving patient outcomes.

Latest Patents

Carol R Reed holds a patent for "CDK5 genetic markers associated with galantamine response." This patent discloses haplotypes in the CDK5 gene that are associated with cognitive response to galantamine treatment. The patent outlines compositions and methods for detecting and utilizing these CDK5 haplotypes in various clinical applications. These applications include articles of manufacture comprising galantamine or its derivatives, which are approved for treating patients with specific CDK5 haplotypes. Additionally, the patent describes methods and kits for predicting an individual's response to galantamine based on their haplotype profile, as well as methods for treating Alzheimer's patients according to their haplotype profile.

Career Highlights

Carol R Reed is currently associated with Pgxhealth, LLC, where she continues to advance her research and innovations. Her work is pivotal in the intersection of genetics and pharmacology, particularly in enhancing the efficacy of treatments for cognitive disorders.

Collaborations

Some of her notable coworkers include Jeroen Aerssens and Maria Athanasiou, who contribute to the collaborative efforts at Pgxhealth, LLC.

Conclusion

Carol R Reed's contributions to the field of genetics and her innovative patent on CDK5 genetic markers highlight her role as a significant inventor in the medical research community. Her work has the potential to transform treatment approaches for Alzheimer's disease and improve patient care.